• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Polymorphisms in pattern-recognition genes in the innate immunity system and risk of non-Hodgkin lymphoma.先天免疫系统中模式识别基因的多态性与非霍奇金淋巴瘤的风险。
Environ Mol Mutagen. 2013 Jan;54(1):72-7. doi: 10.1002/em.21739. Epub 2012 Oct 11.
2
Polymorphisms in DNA repair genes, hair dye use, and the risk of non-Hodgkin lymphoma.DNA修复基因多态性、染发剂使用与非霍奇金淋巴瘤风险
Cancer Causes Control. 2014 Oct;25(10):1261-70. doi: 10.1007/s10552-014-0423-1. Epub 2014 Sep 2.
3
Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development.与调节细胞周期、细胞凋亡和淋巴细胞发育的基因种系变异相关的非霍奇金淋巴瘤风险。
Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1259-70. doi: 10.1158/1055-9965.EPI-08-1037. Epub 2009 Mar 31.
4
Polymorphisms in complement system genes and risk of non-Hodgkin lymphoma.补体系统基因多态性与非霍奇金淋巴瘤风险。
Environ Mol Mutagen. 2012 Mar;53(2):145-51. doi: 10.1002/em.21675. Epub 2011 Dec 15.
5
A pooled analysis of three studies evaluating genetic variation in innate immunity genes and non-Hodgkin lymphoma risk.对评估固有免疫基因遗传变异与非霍奇金淋巴瘤风险的三项研究进行的汇总分析。
Br J Haematol. 2011 Mar;152(6):721-6. doi: 10.1111/j.1365-2141.2010.08518.x. Epub 2011 Jan 20.
6
Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma among women in Connecticut.康涅狄格州女性DNA修复基因多态性与非霍奇金淋巴瘤风险
Hum Genet. 2006 Jul;119(6):659-68. doi: 10.1007/s00439-006-0177-2. Epub 2006 Apr 26.
7
Innate immunity and non-Hodgkin's lymphoma (NHL) related genes in a nested case-control study for gastric cancer risk.固有免疫与非霍奇金淋巴瘤(NHL)相关基因在胃癌风险巢式病例对照研究中的作用。
PLoS One. 2012;7(9):e45274. doi: 10.1371/journal.pone.0045274. Epub 2012 Sep 21.
8
Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk.肿瘤坏死因子(TNF)和TNF受体超家族以及NF-κB转录因子中的常见基因变异与非霍奇金淋巴瘤风险
PLoS One. 2009;4(4):e5360. doi: 10.1371/journal.pone.0005360. Epub 2009 Apr 24.
9
Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.肿瘤坏死因子和核因子-κB经典通路中的基因变异与非霍奇金淋巴瘤风险
Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3161-9. doi: 10.1158/1055-9965.EPI-08-0536.
10
Genetic variation in Th1/Th2 pathway genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies.Th1/Th2 通路基因遗传变异与非霍奇金淋巴瘤风险:三项基于人群的病例对照研究的汇总分析。
Br J Haematol. 2011 May;153(3):341-50. doi: 10.1111/j.1365-2141.2010.08424.x. Epub 2011 Mar 21.

引用本文的文献

1
Complement 4 Aids in the Prediction of Newly Diagnosed Multiple Myeloma Outcome in Patients.补体4有助于预测患者新诊断的多发性骨髓瘤的预后。
Clin Med Insights Oncol. 2022 Feb 28;16:11795549221079171. doi: 10.1177/11795549221079171. eCollection 2022.
2
MASPs at the crossroad between the complement and the coagulation cascades - the case for COVID-19.甘露聚糖结合凝集素相关丝氨酸蛋白酶处于补体和凝血级联反应的交叉点——以新冠肺炎为例
Genet Mol Biol. 2021 Mar 17;44(1 Suppl 1):e20200199. doi: 10.1590/1678-4685-GMB-2020-0199. eCollection 2021.
3
How Does Complement Affect Hematological Malignancies: From Basic Mechanisms to Clinical Application.补体如何影响血液系统恶性肿瘤:从基础机制到临床应用。
Front Immunol. 2020 Oct 29;11:593610. doi: 10.3389/fimmu.2020.593610. eCollection 2020.
4
Components of the Lectin Pathway of Complement in Haematologic Malignancies.血液系统恶性肿瘤中补体凝集素途径的组成成分。
Cancers (Basel). 2020 Jul 4;12(7):1792. doi: 10.3390/cancers12071792.
5
Serum proteome profiles to differentiate Crohn disease from intestinal tuberculosis and primary intestinal lymphoma: A pilot study.用于鉴别克罗恩病与肠结核及原发性肠淋巴瘤的血清蛋白质组图谱:一项初步研究。
Medicine (Baltimore). 2019 Dec;98(50):e18304. doi: 10.1097/MD.0000000000018304.
6
The Role of Complement Activating Collectins and Associated Serine Proteases in Patients With Hematological Malignancies, Receiving High-Dose Chemotherapy, and Autologous Hematopoietic Stem Cell Transplantations (Auto-HSCT).补体激活凝集素和相关丝氨酸蛋白酶在接受大剂量化疗和自体造血干细胞移植(Auto-HSCT)的血液系统恶性肿瘤患者中的作用。
Front Immunol. 2018 Sep 20;9:2153. doi: 10.3389/fimmu.2018.02153. eCollection 2018.
7
Resolving uncertainty in the spatial relationships between passive benzene exposure and risk of non-Hodgkin lymphoma.解决被动接触苯与非霍奇金淋巴瘤风险之间空间关系的不确定性。
Cancer Epidemiol. 2016 Apr;41:139-51. doi: 10.1016/j.canep.2016.01.008. Epub 2016 Mar 2.
8
To Each Its Own: Linking the Biology and Epidemiology of NHL Subtypes.各有其特点:非霍奇金淋巴瘤亚型的生物学与流行病学关联
Curr Hematol Malig Rep. 2015 Sep;10(3):244-55. doi: 10.1007/s11899-015-0267-0.
9
Common infection-related conditions and risk of lymphoid malignancies in older individuals.老年人常见感染相关病症与淋巴恶性肿瘤风险
Br J Cancer. 2014 May 27;110(11):2796-803. doi: 10.1038/bjc.2014.173. Epub 2014 Apr 1.
10
Polymorphisms in JAK/STAT signaling pathway genes and risk of non-Hodgkin lymphoma.JAK/STAT 信号通路基因多态性与非霍奇金淋巴瘤风险。
Leuk Res. 2013 Sep;37(9):1120-4. doi: 10.1016/j.leukres.2013.05.003. Epub 2013 Jun 12.

本文引用的文献

1
Polymorphisms in complement system genes and risk of non-Hodgkin lymphoma.补体系统基因多态性与非霍奇金淋巴瘤风险。
Environ Mol Mutagen. 2012 Mar;53(2):145-51. doi: 10.1002/em.21675. Epub 2011 Dec 15.
2
Polymorphisms in genes involved in innate immunity and susceptibility to benzene-induced hematotoxicity.参与固有免疫和苯致血液毒性易感性的基因多态性。
Exp Mol Med. 2011 Jun 30;43(6):374-8. doi: 10.3858/emm.2011.43.6.041.
3
Infection with hepatitis B and C viruses and risk of lymphoid malignancies in the European Prospective Investigation into Cancer and Nutrition (EPIC).在欧洲癌症与营养前瞻性调查(EPIC)中,乙型和丙型肝炎病毒感染与淋巴恶性肿瘤的风险。
Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):208-14. doi: 10.1158/1055-9965.EPI-10-0889. Epub 2010 Nov 23.
4
Genetic susceptibility for chronic lymphocytic leukemia among Chinese in Hong Kong.香港华人慢性淋巴细胞白血病的遗传易感性。
Eur J Haematol. 2010 Dec;85(6):492-5. doi: 10.1111/j.1600-0609.2010.01518.x.
5
HIV-associated immune dysfunction and viral infection: role in the pathogenesis of AIDS-related lymphoma.HIV 相关免疫功能障碍和病毒感染:在 AIDS 相关淋巴瘤发病机制中的作用。
Immunol Res. 2010 Dec;48(1-3):72-83. doi: 10.1007/s12026-010-8168-8.
6
Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study.韩国乙型肝炎病毒感染与非霍奇金淋巴瘤风险:一项队列研究。
Lancet Oncol. 2010 Sep;11(9):827-34. doi: 10.1016/S1470-2045(10)70167-4. Epub 2010 Aug 3.
7
Verification that common variation at 2q37.1, 6p25.3, 11q24.1, 15q23, and 19q13.32 influences chronic lymphocytic leukaemia risk.验证常见变异 2q37.1、6p25.3、11q24.1、15q23 和 19q13.32 对慢性淋巴细胞白血病风险的影响。
Br J Haematol. 2010 Aug;150(4):473-9. doi: 10.1111/j.1365-2141.2010.08270.x. Epub 2010 Jun 10.
8
Polymorphisms in innate immunity genes and risk of childhood leukemia.先天免疫基因多态性与儿童白血病风险。
Hum Immunol. 2010 Jul;71(7):727-30. doi: 10.1016/j.humimm.2010.04.004. Epub 2010 May 16.
9
Enhanced expression of lymphomagenesis-related genes in peripheral blood B cells of chronic hepatitis C patients.慢性丙型肝炎患者外周血 B 细胞中淋巴瘤相关基因的表达增强。
Clin Immunol. 2010 Jun;135(3):459-65. doi: 10.1016/j.clim.2010.02.002. Epub 2010 Mar 1.
10
Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma.6p21.33 处的基因变异与滤泡性淋巴瘤易感性相关。
Nat Genet. 2009 Aug;41(8):873-5. doi: 10.1038/ng.419. Epub 2009 Jul 20.

先天免疫系统中模式识别基因的多态性与非霍奇金淋巴瘤的风险。

Polymorphisms in pattern-recognition genes in the innate immunity system and risk of non-Hodgkin lymphoma.

机构信息

Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, Maryland 20892-7240, USA.

出版信息

Environ Mol Mutagen. 2013 Jan;54(1):72-7. doi: 10.1002/em.21739. Epub 2012 Oct 11.

DOI:10.1002/em.21739
PMID:23055202
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6800161/
Abstract

The pattern-recognition pathway plays an important role in infection recognition and immune responses, and previous studies have suggested an association between genetic variation in innate immunity genes and non-Hodgkin lymphoma (NHL). We evaluated NHL risk associated with genetic variation in pattern-recognition genes using data from a case-control study of NHL conducted in Connecticut women. Single nucleotide polymorphisms (SNPs) in 27 pattern-recognition genes were genotyped in 432 Caucasian incident NHL cases and 494 frequency-matched controls. Unconditional logistic regression was used to compute odds ratios (ORs) for NHL and common NHL subtypes in relation to individual SNPs and haplotypes. A gene-based analysis that adjusted for the number of tagSNPs genotyped in each gene showed a significant association with overall NHL for the MBP gene (P = 0.028), with the diffuse large B-cell lymphoma (DLBCL) subtype for the MASP2 gene (P = 0.011), and with the follicular lymphoma (FL) subtype for DEFB126 (P = 0.041). A SNP-based analysis showed that MBP rs8094402 was associated with decreased risks of overall NHL (allele risk OR = 0.72, P-trend = 0.0018), DLBCL (allele risk OR = 0.72, P-trend = 0.036), and FL (allele risk OR = 0.67, P-trend = 0.021), while MASP2 rs12711521 was associated with a decreased risk of DLBCL (allele risk OR = 0.57, P-trend = 0.0042). We also observed an increased risk of FL for DEFB126 rs6054706 (allele risk OR = 1.39, P-trend = 0.033). Our results suggest that genetic variation in pattern-recognition genes is associated with the risk of NHL or specific NHL subtypes, but these preliminary findings require replication in larger studies.

摘要

模式识别途径在感染识别和免疫反应中发挥着重要作用,先前的研究表明,固有免疫基因的遗传变异与非霍奇金淋巴瘤(NHL)之间存在关联。我们使用在康涅狄格州女性中进行的 NHL 病例对照研究的数据,评估了模式识别基因遗传变异与 NHL 风险之间的关系。对 432 名白种人 NHL 发病病例和 494 名频数匹配对照的 27 个模式识别基因中的单核苷酸多态性(SNP)进行了基因分型。使用条件逻辑回归计算了个体 SNP 和单倍型与 NHL 和常见 NHL 亚型之间的比值比(OR)。在对每个基因中所检测到的标签 SNP 数量进行校正的基于基因的分析中,MBP 基因与 NHL 总体(P = 0.028)、MASP2 基因与弥漫性大 B 细胞淋巴瘤(DLBCL)亚型(P = 0.011)和 DEFB126 基因与滤泡性淋巴瘤(FL)亚型(P = 0.041)存在显著关联。基于 SNP 的分析表明,MBP rs8094402 与 NHL 总体(等位基因风险 OR = 0.72,P 趋势= 0.0018)、DLBCL(等位基因风险 OR = 0.72,P 趋势= 0.036)和 FL(等位基因风险 OR = 0.67,P 趋势= 0.021)的发病风险降低相关,而 MASP2 rs12711521 与 DLBCL 的发病风险降低相关(等位基因风险 OR = 0.57,P 趋势= 0.0042)。我们还观察到 DEFB126 rs6054706 与 FL 的发病风险增加相关(等位基因风险 OR = 1.39,P 趋势= 0.033)。我们的研究结果表明,模式识别基因的遗传变异与 NHL 或特定 NHL 亚型的风险相关,但这些初步发现需要在更大的研究中得到验证。